Heart devices reduce hospitalization, study says
Wall Street Journal, September 1, 2009
Results from an industry-funded study of cardiac resynchronization therapy defibrillators, medical implants that slow heart deterioration, found benefits more pronounced than in a preliminary analysis in June. But some cardiologists remain skeptical that the findings justify broad use of the $30,000 devices for patients with mild heart failure.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- WellPoint Dominates Nearly Half of Markets, AMA Says
- Defensive Medicine Still Prevalent Despite Tort Reform
- CMS Offers Some ACOs $114M for 'Upfront' Costs